{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:42:03Z","timestamp":1790048523536,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030B_166676"],"award-info":[{"award-number":["310030B_166676"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004361","name":"Krebsliga Schweiz","doi-asserted-by":"publisher","award":["KFS-4147-02-2017"],"award-info":[{"award-number":["KFS-4147-02-2017"]}],"id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>To increase the size of the druggable proteome, it would be highly desirable to devise efficient methods to translocate designed binding proteins to the cytosol, as they could specifically target flat and hydrophobic protein-protein interfaces. If this could be done in a manner dependent on a cell surface receptor, two layers of specificity would be obtained: one for the cell type and the other for the cytosolic target. Bacterial protein toxins have naturally evolved such systems. Anthrax toxin consists of a pore-forming translocation unit (protective antigen (PA)) and a separate protein payload. When engineering PA to ablate binding to its own receptor and instead binding to a receptor of choice, by fusing a designed ankyrin repeat protein (DARPin), uptake in new cell types can be achieved.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Prepore-to-pore conversion of redirected PA already occurs at the cell surface, limiting the amount of PA that can be administered and thus limiting the amount of delivered payload. We hypothesized that the reason is a lack of a stabilizing interaction with wild-type PA receptor. We have now reengineered PA to incorporate the binding domain of the anthrax receptor CMG2, followed by a DARPin, binding to the receptor of choice. This construct is indeed stabilized, undergoes prepore-to-pore conversion only in late endosomes, can be administered to much higher concentrations without showing toxicity, and consequently delivers much higher amounts of payload to the cytosol.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>We believe that this reengineered system is an important step forward to addressing efficient cell-specific delivery of proteins to the cytosol.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12915-020-00827-y","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T14:03:58Z","timestamp":1597327438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Reengineering anthrax toxin protective antigen for improved receptor-specific protein delivery"],"prefix":"10.1186","volume":"18","author":[{"given":"Lukas","family":"Becker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter P. R.","family":"Verdurmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4191-5306","authenticated-orcid":false,"given":"Andreas","family":"Pl\u00fcckthun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"key":"827_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrd892","volume":"1","author":"AL Hopkins","year":"2002","unstructured":"Hopkins AL, Groom CR. The druggable genome. Nat Rev Drug Discov. 2002;1:727\u201330.","journal-title":"Nat Rev Drug Discov"},{"key":"827_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.tips.2013.04.007","volume":"34","author":"AA Ivanov","year":"2013","unstructured":"Ivanov AA, Khuri FR, Fu H. Targeting protein\u2013protein interactions as an anticancer strategy. Trends Pharmacol Sci. 2013;34:393\u2013400.","journal-title":"Trends Pharmacol Sci"},{"key":"827_CR3","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1021\/acs.bioconjchem.9b00112","volume":"30","author":"K Deprey","year":"2019","unstructured":"Deprey K, Becker L, Kritzer J, Pl\u00fcckthun A. Trapped! A critical evaluation of methods for measuring total cellular uptake versus cytosolic localization. Bioconjug Chem. 2019;30:1006\u201327.","journal-title":"Bioconjug Chem"},{"key":"827_CR4","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1021\/acschembio.6b00169","volume":"11","author":"AE Rabideau","year":"2016","unstructured":"Rabideau AE, Pentelute BL. Delivery of non-native cargo into mammalian cells using anthrax lethal toxin. ACS Chem Biol. 2016;11:1490\u2013501.","journal-title":"ACS Chem Biol"},{"key":"827_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bcp.2017.04.009","volume":"142","author":"GL Beilhartz","year":"2017","unstructured":"Beilhartz GL, Sugiman-Marangos SN, Melnyk RA. Repurposing bacterial toxins for intracellular delivery of therapeutic proteins. Biochem Pharmacol. 2017;142:13\u201320.","journal-title":"Biochem Pharmacol"},{"key":"827_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/toxins8030069","volume":"8","author":"S Friebe","year":"2016","unstructured":"Friebe S, van der Goot F, B\u00fcrgi J. The ins and outs of anthrax toxin. Toxins. 2016;8:69.","journal-title":"Toxins"},{"key":"827_CR7","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1083\/jcb.200312072","volume":"166","author":"L Abrami","year":"2004","unstructured":"Abrami L, Lindsay M, Parton RG, Leppla SH, van der Goot FG. Membrane insertion of anthrax protective antigen and cytoplasmic delivery of lethal factor occur at different stages of the endocytic pathway. J Cell Biol. 2004;166:645\u201351.","journal-title":"J Cell Biol"},{"key":"827_CR8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1097\/CJI.0b013e3181ad4d5d","volume":"32","author":"R Zielinski","year":"2009","unstructured":"Zielinski R, Lyakhov I, Jacobs A, Chertov O, Kramer-Marek G, Francella N, et al. Affitoxin\u2014a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors. J Immunother. 2009;32:817\u201325.","journal-title":"J Immunother"},{"key":"827_CR9","doi-asserted-by":"publisher","first-page":"e00088","DOI":"10.1128\/mBio.00088-12","volume":"3","author":"A Mechaly","year":"2012","unstructured":"Mechaly A, McCluskey AJ, Collier RJ. Changing the receptor specificity of anthrax toxin. mBio. 2012;3:e00088\u201312.","journal-title":"mBio"},{"key":"827_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jconrel.2014.12.019","volume":"200","author":"WPR Verdurmen","year":"2015","unstructured":"Verdurmen WPR, Luginb\u00fchl M, Honegger A, Pl\u00fcckthun A. Efficient cell-specific uptake of binding proteins into the cytoplasm through engineered modular transport systems. J Control Release. 2015;200:13\u201322.","journal-title":"J Control Release"},{"key":"827_CR11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.molonc.2012.12.003","volume":"7","author":"AJ McCluskey","year":"2013","unstructured":"McCluskey AJ, Olive AJ, Starnbach MN, Collier RJ. Targeting HER2-positive cancer cells with receptor-redirected anthrax protective antigen. Mol Oncol. 2013;7:440\u201351.","journal-title":"Mol Oncol"},{"key":"827_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF03401732","volume":"4","author":"M Varughese","year":"1998","unstructured":"Varughese M, Chi A, Teixeira AV, Nicholls PJ, Keith JM, Leppla SH. Internalization of a Bacillus anthracis protective antigen-c-Myc fusion protein mediated by cell surface anti-c-Myc antibodies. Mol Med. 1998;4:87\u201395.","journal-title":"Mol Med"},{"key":"827_CR13","doi-asserted-by":"publisher","first-page":"13147","DOI":"10.1073\/pnas.0405405101","volume":"101","author":"DB Lacy","year":"2004","unstructured":"Lacy DB, Wigelsworth DJ, Melnyk RA, Harrison SC, Collier RJ. Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation. Proc Natl Acad Sci. 2004;101:13147\u201351.","journal-title":"Proc Natl Acad Sci"},{"key":"827_CR14","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nature14247","volume":"521","author":"J Jiang","year":"2015","unstructured":"Jiang J, Pentelute BL, Collier RJ, Zhou ZH. Atomic structure of anthrax protective antigen pore elucidates toxin translocation. Nature. 2015;521:545\u20139.","journal-title":"Nature"},{"key":"827_CR15","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.jmb.2011.09.016","volume":"413","author":"N Stefan","year":"2011","unstructured":"Stefan N, Martin-Killias P, Wyss-Stoeckle S, Honegger A, Zangemeister-Wittke U, Pl\u00fcckthun A. DARPins recognizing the tumor-associated antigen EpCAM selected by phage and ribosome display and engineered for multivalency. J Mol Biol. 2011;413:826\u201343.","journal-title":"J Mol Biol"},{"key":"827_CR16","doi-asserted-by":"publisher","first-page":"30936","DOI":"10.1074\/jbc.M301154200","volume":"278","author":"MJ Rosovitz","year":"2003","unstructured":"Rosovitz MJ, Schuck P, Varughese M, Chopra AP, Mehra V, Singh Y, et al. Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody. J Biol Chem. 2003;278:30936\u201344.","journal-title":"J Biol Chem"},{"key":"827_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013888","volume":"5","author":"AF Kintzer","year":"2010","unstructured":"Kintzer AF, Sterling HJ, Tang II, Williams ER, Krantz BA. Anthrax toxin receptor drives protective antigen oligomerization and stabilizes the heptameric and octameric oligomer by a similar mechanism. PLoS One. 2010;5:e13888.","journal-title":"PLoS One"},{"key":"827_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/pro.2206","volume":"22","author":"VP Reddy Chichili","year":"2013","unstructured":"Reddy Chichili VP, Kumar V, Sivaraman J. Linkers in the structural biology of protein-protein interactions: linkers in structural biology. Protein Sci. 2013;22:153\u201367.","journal-title":"Protein Sci"},{"key":"827_CR19","doi-asserted-by":"publisher","first-page":"13194","DOI":"10.1038\/s41598-017-13469-y","volume":"7","author":"WPR Verdurmen","year":"2017","unstructured":"Verdurmen WPR, Mazlami M, Pl\u00fcckthun A. A quantitative comparison of cytosolic delivery via different protein uptake systems. Sci Rep. 2017;7:13194.","journal-title":"Sci Rep"},{"key":"827_CR20","doi-asserted-by":"publisher","first-page":"18568","DOI":"10.1038\/s41598-019-54939-9","volume":"9","author":"M Chernyavska","year":"2019","unstructured":"Chernyavska M, Schmid M, Freitag PC, Palacio-Casta\u00f1eda V, Piruska A, Huck WTS, et al. Unravelling receptor and RGD motif dependence of retargeted adenoviral vectors using advanced tumor model systems. Sci Rep. 2019;9:18568.","journal-title":"Sci Rep"},{"key":"827_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1128\/IAI.63.1.82-87.1995","volume":"63","author":"VM Gordon","year":"1995","unstructured":"Gordon VM, Klimpel KR, Arora N, Henderson MA, Leppla SH. Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infect Immun. 1995;63:82\u20137.","journal-title":"Infect Immun"},{"key":"827_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-1-4939-6857-2_14","volume-title":"Synthetic antibodies","author":"WPR Verdurmen","year":"2017","unstructured":"Verdurmen WPR, Mazlami M, Pl\u00fcckthun A. A biotin ligase-based assay for the quantification of the cytosolic delivery of therapeutic proteins. In: Tiller T, editor. Synthetic antibodies. New York: Springer New York; 2017. p. 223\u201336. https:\/\/doi.org\/10.1007\/978-1-4939-6857-2_14."},{"key":"827_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nmeth1010","volume":"4","author":"MZ Li","year":"2007","unstructured":"Li MZ, Elledge SJ. Harnessing homologous recombination in vitro to generate recombinant DNA via SLIC. Nat Methods. 2007;4:251\u20136.","journal-title":"Nat Methods"},{"key":"827_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-62703-691-7_2","volume-title":"Structural genomics","author":"FW Studier","year":"2014","unstructured":"Studier FW. Stable expression clones and auto-induction for protein production in E. coli. In: Chen YW, editor. Structural genomics. Totowa: Humana Press; 2014. p. 17\u201332. https:\/\/doi.org\/10.1007\/978-1-62703-691-7_2."}],"container-title":["BMC Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-020-00827-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12915-020-00827-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-020-00827-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:14:03Z","timestamp":1628813643000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiol.biomedcentral.com\/articles\/10.1186\/s12915-020-00827-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["827"],"URL":"https:\/\/doi.org\/10.1186\/s12915-020-00827-y","relation":{},"ISSN":["1741-7007"],"issn-type":[{"value":"1741-7007","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]},"assertion":[{"value":"2 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}